Indevus Pharmaceuticals, Inc.

Pfizer Corporation

Sean Donevan

Atul Pande

Jeroen Van Beek

Richard Kavoussi

Cathryn M Clary

Perry S Eisman

Lyou-Fu Ma

David Juergen Wustrow

Andrew John Thorpe

Augustine Tobi Osuma

The present invention provides methods for treating social anxiety disorder, comprising administering 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone or 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-5-hydroxy-2-oxohexyl) -1-isoindolinone or pharmaceutically acceptable salt, or optical isomer therof, and optionally comprising administering another compound for the treatment of social anxiety disorder that is a GABA agonist.

Use of pagoclone for the treatment of social anxiety disorder

This invention relates to prodrugs of certain amino acids that bind to the alpha-2-delta (&#x3b1;2&#x3b4;) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.

Prodrugs of amino acids with affinity for the &#x3b1;2&#x3b4;-protein

Methods of treating obsessive-compulsive disorder comprising administering-(-chloro--naphthyridin--yl)--(-methyl--oxo-hexyl)--isoindolinone are disclosed.

Methods of treating obsessive-compulsive disorder

Growing community of inventors

Dexter, MI, United States of America

Sean Donevan